Know Cancer

or
forgot password

Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis


N/A
21 Years
N/A
Not Enrolling
Both
Lung Cancer, Prostate Cancer, Colorectal Cancer, Hepatocellular Carcinoma, Breast Cancer

Thank you

Trial Information

Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis


The CREATE Project encompasses three phases, the first and second of which do not contain
interventions. The first phase of the project determines the effectiveness of computerized
queries we develop to accurately identify which patients are at risk for delays in cancer
diagnosis. Patients we identify will have abnormal test results or symptoms that have not
been followed up by their providers. In Phase 2 of the study, the research team will use
interviewing and other participatory techniques to determine the best way to convey
information about such at-risk patients to providers in an automated fashion. In Phase 3 of
the project, we will evaluate the effects of an automated surveillance intervention on the
timeliness of the diagnostic process of five cancers.

This project will improve communication and coordination of cancer-related diagnostic
information to improve quality and safety.


Inclusion Criteria:



- Physicians, nurses, and other providers that are part of Veteran's Affairs Hospitals'
PACTs (Patient Aligned Care Teams)at both study sites who agree to participate in the
study

- Intervention will be performed on those providers whose patients are electronically
identified to have suspected cancer defined as presence of any predefined clue for
cancer that is not followed-up in a timely manner.

- Five cancers are included:

- colorectal

- lung

- prostate

- hepatocellular carcinoma

- breast cancer

- Patients will be selected from the data warehouse.

Exclusion Criteria:

- Patient Aligned Care Teams (PACTs) at both study sites who do not wish to participate
in the study.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Health Services Research

Outcome Measure:

Timeliness of Diagnosis

Outcome Description:

We will conduct chart reviews of patients shown by our automated surveillance system to have not received appropriate follow-up care in both intervention and control groups at least 6 months after the first documentation of a diagnostic clue (e.g., initial abnormal chest X-ray). Chart review will be used to quantify time in days from documentation of the clinical clue to the time when follow-up action on that clue was initiated.

Outcome Time Frame:

1 year

Safety Issue:

Yes

Principal Investigator

Hardeep Singh, MD MPH BS

Investigator Role:

Principal Investigator

Investigator Affiliation:

Michael E DeBakey VA Medical Center

Authority:

United States: Federal Government

Study ID:

CRE 12-033

NCT ID:

NCT01710293

Start Date:

January 2015

Completion Date:

January 2017

Related Keywords:

  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Hepatocellular Carcinoma
  • Breast Cancer
  • Breast Neoplasms
  • Carcinoma
  • Colorectal Neoplasms
  • Lung Neoplasms
  • Prostatic Neoplasms
  • Carcinoma, Hepatocellular

Name

Location
Michael E DeBakey VA Medical Center Houston, Texas  77030
Jesse Brown VA Medical Center, Chicago, IL Chicago, Illinois  60612